Profil
Bruce N.
Rogers is currently the President at Morphic Therapeutic, Inc. He previously worked as the Head-Neuro Opportunities at Pfizer Inc. from 2014 to 2016 and as a Scientist at Pharmacia & Upjohn Co. LLC from 1998 to 2003.
Additionally, he served as the President at Morphic Holding, Inc. in 2024.
Dr. Rogers holds a doctorate degree from the University of California, Irvine and an undergraduate degree from the University of Minnesota.
Postes actifs de Bruce Rogers
| Sociétés | Poste | Début |
|---|---|---|
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | President | 01/05/2022 |
Anciens postes connus de Bruce Rogers
| Sociétés | Poste | Fin |
|---|---|---|
| MORC HOLD | Directeur Général | 02/01/2024 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2016 |
Pharmacia & Upjohn Co. LLC
Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical goods | Corporate Officer/Principal | 01/08/2003 |
Formation de Bruce Rogers
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia & Upjohn Co. LLC
Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical goods | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
















